Kyle Gutsadt | Investor Relations |
Joseph Payne | President and Chief Executive Officer |
Andrew Sassine | Chief Financial Officer |
Padmanabh Chivukula | Chief Scientific Officer and Chief Operating Officer |
Seamus Fernandez | Guggenheim |
Yigal Nochomovitz | Citi |
Pete Stavropoulos | Cantor Fitzgerald |
Yale Jen | Laidlaw and Company |
Yanan Zhu | Wells Fargo Securities |
Good day ladies and gentlemen and welcome to the Arcturus Therapeutics Third Quarter 2022 Earnings Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Kyle Gutsadt, Senior Analyst, Investor & Public Relations. Please go ahead, sir.
Thank you, Keith.